Scenarios that move PLRX

Pliant Therapeutics, Inc. - Common Stock

Scenarios that move PLRX: 1 analysis, 1 positive, 0 negative.

1. 2026-10-14 · Syndax stock falls 16% as Phase II fibrosis study misses primary goal — ▲ · impact +45 · confidence medium · horizon immediate

All scenarios · Run a scenario · Pricing